ANVISA, Brazil’s Health Surveillance Agency, has approved sale of Kemin’s ZeaONE.
Photo ©iStockphoto.com/geopaul
ANVISA, Brazil’s Health Surveillance Agency, has approved for sale ZeaONE Zeaxanthin from Kemin Health LC (Des Moines,IA). The news allows Kemin to begin immediate marketing in Brazil of ZeaONE, a zeaxanthin ingredient sourced from a parented line of marigolds.
Like lutein, zeaxanthin has shown promise for health conditions like skin health and eye health in multiple scientific studies. In a recent age-related eye disease study from the U.S. National Eye Institute (AREDS2), 2 mg of zeaxanthin plus 10 mg of Kemin’s FloraGLO lutein was found to “slow the progression of age-related macular degeneration.”
ZeaONE is commercially available under the OptiSharp Natural brand from DSM (Parsippany, NJ).
Read more:
Fierce Debate over Zeaxanthin Isomers
Lutein and Zeaxanthin Benefit Young and Old Alike
Michael Crane
Associate Editor
Nutritional Outlook Magazine
michael.crane@ubm.com
NutriSciences Innovations announces acquisition of XSTO Solutions
October 22nd 2024According to the company’s press release, the strategic acquisition adds six new branded products to the NutriScience portfolio, strengthening its role as a preferred ingredient supplier to leading brands in the wellness, food, and beverage industries.